Immunic, Inc. · NASDAQ:IMUX
Aberdeen Group plc reported a 7.99% stake in Immunic, Inc. (Schedule 13G/A)
Event Sep 30, 2026 · Filed Nov 2, 2026
Aberdeen Group plc reported a 7.99% stake in Immunic, Inc., 1,090,427 shares, as a passive investor on Sep 30, 2026. Filed Nov 2, 2026 (Schedule 13G/A).
- Stake
- 7.99%
- Shares
- 1,090,427
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Aberdeen Group plc | 7.99% | 1,090,427 |
| abrdn Inc. | 7.99% | 1,090,427 |
Source
Download original · View original at SEC
Related
- Immunic, Inc.
- Aberdeen Group plc
- Immunic, Inc. shareholders
- Schedule 13G/A · Aberdeen Group plc · Jul 16, 2026
- Schedule 13G/A · Millennium Management LLC · Nov 16, 2026
- Schedule 13G · Morgan Stanley · Nov 13, 2026
- Schedule 13G/A · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Commodore Capital LP · Aug 14, 2026
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · Aug 13, 2026